These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36714337)

  • 1. Advances in gastric cancer research will light the way to control this cancer.
    de Assumpção PP; Burbano RR
    Chin J Cancer Res; 2022 Dec; 34(6):575-578. PubMed ID: 36714337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported.
    de Assumpção PB; de Assumpção PP; Moreira FC; Ribeiro-Dos-Santos Â; Vidal AF; Magalhães L; Khayat AS; Ribeiro-Dos-Santos AM; Cavalcante GC; Pereira AL; Medeiros I; de Souza SJ; Burbano RMR; de Souza JES; Dos Santos SEB
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
    Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
    Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and applicability of molecular classifications for gastric cancer.
    Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
    Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.
    Zheng G; Sundquist K; Sundquist J; Chen T; Försti A; Hemminki A; Hemminki K
    Clin Epidemiol; 2021; 13():515-525. PubMed ID: 34239328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of in vitro and in vivo models of oesophageal and gastric cancer.
    Mukherji D; Benepal T
    Expert Opin Drug Discov; 2009 Dec; 4(12):1267-79. PubMed ID: 23480466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in gastric cancer research: Benefits and challenges.
    Li JJ; Qi RZ; Ng GK; Xie D
    Proteomics Clin Appl; 2009 Feb; 3(2):185-96. PubMed ID: 26238618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.
    Garcia-Pelaez J; Barbosa-Matos R; São José C; Sousa S; Gullo I; Hoogerbrugge N; Carneiro F; Oliveira C
    Eur J Med Genet; 2022 Jan; 65(1):104401. PubMed ID: 34871783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Organoids: Progress and Remaining Challenges.
    Pang MJ; Burclaff JR; Jin R; Adkins-Threats M; Osaki LH; Han Y; Mills JC; Miao ZF; Wang ZN
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):19-33. PubMed ID: 34547535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine in gastric cancer.
    Bonelli P; Borrelli A; Tuccillo FM; Silvestro L; Palaia R; Buonaguro FM
    World J Gastrointest Oncol; 2019 Oct; 11(10):804-829. PubMed ID: 31662821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
    Hayakawa Y; Sethi N; Sepulveda AR; Bass AJ; Wang TC
    Nat Rev Cancer; 2016 Apr; 16(5):305-18. PubMed ID: 27112208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
    Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration.
    Ooki A; Yamaguchi K
    Gastric Cancer; 2021 Nov; 24(6):1169-1183. PubMed ID: 34398359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
    Park WC; Kim HR; Kang DB; Ryu JS; Choi KH; Lee GO; Yun KJ; Kim KY; Park R; Yoon KH; Cho JH; Lee YJ; Chae SC; Park MC; Park DS
    BMC Cancer; 2016 Jun; 16():358. PubMed ID: 27282379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
    Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
    World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer.
    Wu MS; Chen CJ; Lin JT
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1878-82. PubMed ID: 16103430
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.